peripheral arterial disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)patients diagnosed as peripheral arterial disease and scheduled endvascular therapy for de novo superficial femoral artery lesions 2)patients aged over 20 years at the time of informed consent 3)patients who can undestand this study and provide informed consent written 4)ankle brachial index 0.9 5)PAD(Tasc A or B categories) 6)PAD(Rutherford 1-5 categories)
Exclusion criteria
Exclusion criteria: 1)terminal illness in whom life expectancy is expected to be less than 6 months 2)previous stent implantation in the targeted SFA lesion 3)acute limb ischemia or acute thrombotic occlusion 4)patients with no arterial runoff below the knee 5)patients with uncontrollable heart failure 6)patients can not recieve antiplatelet therapy 7)female patients during pregnancy or breast-feeding 8)patients who are judged inappropriate for this trial by their attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| presence of restenosis by ultrasound at 6 months after balloon angioplasty | — |
Secondary
| Measure | Time frame |
|---|---|
| Rutherford category at 6 months after balloon angioplasty | — |
Countries
Japan
Contacts
Department of Internal Medicine, Kobe University Graduate School of Medicine Division of Cardiovascular Medicine